- Home
- ABCL vs AAMI Comparison
ABCL vs AAMI Comparison
Compare ABCL & AAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABCL
- AAMI
- Stock Information
- Founded
- ABCL 2012
- AAMI 1980
- Country
- ABCL Canada
- AAMI United States
- Employees
- ABCL N/A
- AAMI N/A
- Industry
- ABCL Biotechnology: Pharmaceutical Preparations
- AAMI Investment Managers
- Sector
- ABCL Health Care
- AAMI Finance
- Exchange
- ABCL Nasdaq
- AAMI Nasdaq
- Market Cap
- ABCL 818.2M
- AAMI 978.8M
- IPO Year
- ABCL 2020
- AAMI N/A
- Fundamental
- Price
- ABCL $2.23
- AAMI $25.81
- Analyst Decision
- ABCL Buy
- AAMI Hold
- Analyst Count
- ABCL 3
- AAMI 1
- Target Price
- ABCL $7.00
- AAMI $27.00
- AVG Volume (30 Days)
- ABCL 3.8M
- AAMI 242.8K
- Earning Date
- ABCL 05-06-2025
- AAMI 05-01-2025
- Dividend Yield
- ABCL N/A
- AAMI 0.15%
- EPS Growth
- ABCL N/A
- AAMI 43.23
- EPS
- ABCL N/A
- AAMI 2.22
- Revenue
- ABCL $28,833,000.00
- AAMI $505,600,000.00
- Revenue This Year
- ABCL N/A
- AAMI $5.10
- Revenue Next Year
- ABCL $27.77
- AAMI $7.83
- P/E Ratio
- ABCL N/A
- AAMI $11.63
- Revenue Growth
- ABCL N/A
- AAMI 18.52
- 52 Week Low
- ABCL $2.11
- AAMI $21.45
- 52 Week High
- ABCL $4.75
- AAMI $31.52
- Technical
- Relative Strength Index (RSI)
- ABCL 36.73
- AAMI N/A
- Support Level
- ABCL $2.32
- AAMI N/A
- Resistance Level
- ABCL $2.60
- AAMI N/A
- Average True Range (ATR)
- ABCL 0.13
- AAMI 0.00
- MACD
- ABCL 0.01
- AAMI 0.00
- Stochastic Oscillator
- ABCL 13.95
- AAMI 0.00
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
About AAMI Acadian Asset Management Inc. Common Stock
Acadian Asset Management Inc is a diversified, multi-boutique asset management company. It offers institutional investors across the globe access to a wide array of systematic strategies designed to meet a range of risk and return objectives.